Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 3927-3933

  St Leger, Anthony J ^a,b   Peters, Bjoern ^c   Sidney, John ^c   Sette, Alessandro ^c   Hendricks, Robert L ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN B; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS; EARLY GENE; EFFECTOR CELL; FEMALE; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMEDIATE EARLY GENE; LEAKY LATE GENE; LYMPHOCYTE ACTIVATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RECEPTOR BINDING; TRIGEMINUS GANGLION; TRUE LATE GENE; VERO CELL; VIRUS CELL INTERACTION; VIRUS GENE;

ACUTE DISEASE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMUNODOMINANT EPITOPES; KERATITIS, HERPETIC; MICE; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL; TRIGEMINAL GANGLION; VIRUS LATENCY;

EID: 79954991080     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003735     Document Type: Article

References (50)

1. Cohen, J. 2010. Immunology. Painful failure of promising genital herpes vaccine. Science 330: 304.
2. de Bruyn, G., M. Vargas-Cortez, T. Warren, S. K. Tyring, K. H. Fife, J. Lalezari, R. C. Brady, M. Shahmanesh, G. Kinghorn, K. R. Beutner, et al. 2006. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects. Vaccine 24: 914-920. (Pubitemid 43185307)
3. Theil, D., T. Derfuss, I. Paripovic, S. Herberger, E. Meinl, O. Schueler, M. Strupp, V. Arbusow, and T. Brandt. 2003. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. 163: 2179-2184. (Pubitemid 37466462)
4. Verjans, G. M. G. M., R. Q. Hintzen, J. M. van Dun, A. Poot, J. C. Milikan, J. D. Laman, A. W. Langerak, P. R. Kinchington, and A. D. M. E. Osterhaus. 2007. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. USA 104: 3496-3501. (Pubitemid 46364187)
5. Dong, L., P. Li, T. Oenema, C. L. McClurkan, and D. M. Koelle. 2010. Public TCR use by herpes simplex virus-2-specific human CD8 CTLs. J. Immunol. 184: 3063-3071.
6. Koelle, D. M., H. B. Chen, M. A. Gavin, A. Wald, W. W. Kwok, and L. Corey. 2001. CD8 CTL from genital herpes simplex lesions: Recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol. 166: 4049-4058. (Pubitemid 32224935)
7. Chentoufi, A. A., X. Zhang, K. Lamberth, G. Dasgupta, I. Bettahi, A. Nguyen, M.Wu, X. Zhu, A. Mohebbi, S. Buus, et al. 2008. HLA-A*0201- restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. J. Immunol. 180: 426-437.
8. Wallace, M. E., R. Keating, W. R. Heath, and F. R. Carbone. 1999. The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J. Virol. 73: 7619-7626. (Pubitemid 29383246)
9. Salvucci, L. A., R. H. Bonneau, and S. S. Tevethia. 1995. Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes. J. Virol. 69: 1122-1131.
10. Smith, I. L., M. A. Hardwicke, and R. M. Sandri-Goldin. 1992. Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 186: 74-86.
11. Honess, R. W., and B. Roizman. 1974. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14: 8-19.
12. Johnson, P. A., C. MacLean, H. S. Marsden, R. G. Dalziel, and R. D. Everett. 1986. The product of gene US11 of herpes simplex virus type 1 is expressed as a true late gene. J. Gen. Virol. 67: 871-883. (Pubitemid 16084002)
13. Khanna, K. M., R. H. Bonneau, P. R. Kinchington, and R. L. Hendricks. 2003. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18: 593-603. (Pubitemid 36588577)
14. Sheridan, B. S., T. L. Cherpes, J. Urban, P. Kalinski, and R. L. Hendricks. 2009. Reevaluating the CD8 T-cell response to herpes simplex virus type 1: Involvement of CD8 T cells reactive to subdominant epitopes. J. Virol. 83: 2237-2245.
15. Udaka, K., K. H. Wiesmüller, S. Kienle, G. Jung, H. Tamamura, H. Yamagishi, K. Okumura, P. Walden, T. Suto, and T. Kawasaki. 2000. An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 51: 816-828. (Pubitemid 30612045)
16. Sidney, J., S. Southwood, C. Oseroff, M. F. del Guercio, A. Sette, and H. M. Grey. 2001. Measurement of MHC/peptide interactions by gel filtration. Curr. Protoc. Immunol. Chapter 18: Unit 18.3.
17. Vitiello, A., L. Yuan, R. W. Chesnut, J. Sidney, S. Southwood, P. Farness, M. R. Jackson, P. A. Peterson, and A. Sette. 1996. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. J. Immunol. 157: 5555-5562. (Pubitemid 126448977)
18. Cheng, Y., andW. H. Prusoff. 1973. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108.
19. Gulukota, K., J. Sidney, A. Sette, and C. DeLisi. 1997. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J. Mol. Biol. 267: 1258-1267. (Pubitemid 27192636)
20. La Gruta, N. L., P. C. Doherty, and S. J. Turner. 2006. A correlation between function and selected measures of T cell avidity in influenza virus-specific CD8+ T cell responses. Eur. J. Immunol. 36: 2951-2959. (Pubitemid 44782569)
21. Frank, G. M., A. J. Lepisto, M. L. Freeman, B. S. Sheridan, T. L. Cherpes, and R. L. Hendricks. 2010. Early CD4(+) T cell help prevents partial CD8(+) T cell exhaustion and promotes maintenance of Herpes Simplex Virus 1 latency. J. Immunol. 184: 277-286.
22. Kotturi, M. F., B. Peters, F. Buendia-Laysa, Jr., J. Sidney, C. Oseroff, J. Botten, H. Grey, M. J. Buchmeier, and A. Sette. 2007. The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: Uncovering new tricks for an old virus. J. Virol. 81: 4928-4940. (Pubitemid 46744404)
23. Lang, A., and J. Nikolich-Zugich. 2005. Development and migration of protective CD8+ T cells into the nervous system following ocular herpes simplex virus-1 infection. J. Immunol. 174: 2919-2925. (Pubitemid 40279710)
24. Rajcáni, J., V. Andrea, and R. Ingeborg. 2004. Peculiarities of herpes simplex virus (HSV) transcription: An overview. Virus Genes 28: 293-310. (Pubitemid 39012131)
25. Freeman, M. L., K. G. Lanzer, T. Cookenham, B. Peters, J. Sidney, T.-T. Wu, R. Sun, D. L. Woodland, A. Sette, and M. A. Blackman. 2010. Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection. J. Virol. 84: 2881-2892.
26. Moutaftsi, M., S. Salek-Ardakani, M. Croft, B. Peters, J. Sidney, H. Grey, and A. Sette. 2009. Correlates of protection efficacy induced by vaccinia virusspecific CD8+ T-cell epitopes in the murine intranasal challenge model. Eur. J. Immunol. 39: 717-722.
27. Kotturi, M. F., I. Scott, T. Wolfe, B. Peters, J. Sidney, H. Cheroutre, M. G. von Herrath, M. J. Buchmeier, H. Grey, and A. Sette. 2008. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J. Immunol. 181: 2124-2133.
28. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Köppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375: 606-611.
29. Yewdell, J. W. 2006. Confronting complexity: Real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25: 533-543. (Pubitemid 44529047)
30. Moutaftsi, M., D. C. Tscharke, K. Vaughan, D. M. Koelle, L. Stern, M. Calvo- Calle, F. Ennis, M. Terajima, G. Sutter, S. Crotty, et al. 2010. Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. Future Microbiol. 5: 221-239.
31. Mikloska, Z., A. M. Kesson, M. E. T. Penfold, and A. L. Cunningham. 1996. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-g. J. Infect. Dis. 173: 7-17. (Pubitemid 26006797)
32. D. M. Knipe, P. M. Howley, and D. E. Griffin, eds. 2007. Fields' Virology. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia.
33. Hoshino, Y., L. Pesnicak, J. I. Cohen, and S. E. Straus. 2007. Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells. J. Virol. 81: 8157-8164. (Pubitemid 47101502)
34. Smith, C. M., G. T. Belz, N. S. Wilson, J. A. Villadangos, K. Shortman, F. R. Carbone, and W. R. Heath. 2003. Cutting edge: Conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170: 4437-4440. (Pubitemid 36519947)
35. Allan, R. S., C. M. Smith, G. T. Belz, A. L. van Lint, L. M. Wakim, W. R. Heath, and F. R. Carbone. 2003. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301: 1925-1928. (Pubitemid 37229056)
36. Allan, R. S., J. Waithman, S. Bedoui, C. M. Jones, J. A. Villadangos, Y. Zhan, A. M. Lew, K. Shortman, W. R. Heath, and F. R. Carbone. 2006. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25: 153-162. (Pubitemid 44066832)
37. Jirmo, A. C., C.-H. Nagel, C. Bohnen, B. Sodeik, and G. M. N. Behrens. 2009. Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1. J. Immunol. 182: 283-292.
38. Sprecher, E., and Y. Becker. 1989. Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity. Arch. Virol. 107: 191-205. (Pubitemid 19272083)
39. Geraghty, R. J., C. Krummenacher, G. H. Cohen, R. J. Eisenberg, and P. G. Spear. 1998. Entry of alphaherpesviruses mediated by poliovirus receptorrelated protein 1 and poliovirus receptor. Science 280: 1618-1620. (Pubitemid 28277708)
40. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427-436. (Pubitemid 26374317)
41. Chiu, Y. G., W. J. Bowers, S. T. Lim, D. A. Ryan, and H. J. Federoff. 2009. Effects of herpes simplex virus amplicon transduction on murine dendritic cells. Hum. Gene Ther. 20: 442-452.
42. Mikloska, Z., L. Bosnjak, and A. L. Cunningham. 2001. Immature monocytederived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 75: 5958-5964. (Pubitemid 32553126)
43. Kruse, M., O. Rosorius, F. Krätzer, G. Stelz, C. Kuhnt, G. Schuler, J. Hauber, and A. Steinkasserer. 2000. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 74: 7127-7136. (Pubitemid 30470697)
44. Chen, W., C. C. Norbury, Y. Cho, J. W. Yewdell, and J. R. Bennink. 2001. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193: 1319-1326. (Pubitemid 32524782)
45. Stock, A. T., C. M. Jones, W. R. Heath, and F. R. Carbone. 2006. CTL response compensation for the loss of an immunodominant class I-restricted HSV-1 determinant. Immunol. Cell Biol. 84: 543-550. (Pubitemid 44657027)
46. Blaney, J. E., Jr., E. Nobusawa, M. A. Brehm, R. H. Bonneau, L. M. Mylin, T.- M. Fu, Y. Kawaoka, and S. S. Tevethia. 1998. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity. J. Virol. 72: 9567-9574. (Pubitemid 28520820)
47. Bonneau, R. H., L. A. Salvucci, D. C. Johnson, and S. S. Tevethia. 1993. Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones. Virology 195: 62-70.
48. Laing, K. J., A. S. Magaret, D. E. Mueller, L. Zhao, C. Johnston, S. C. De Rosa, D. M. Koelle, A.Wald, and L. Corey. 2010. Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes. J. Clin. Immunol. 30: 703-722.
49. Hosken, N., P. McGowan, A. Meier, D. M. Koelle, P. Sleath, F. Wagener, M. Elliott, K. Grabstein, C. Posavad, and L. Corey. 2006. Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes. J. Virol. 80: 5509-5515.
50. Decman, V., P. R. Kinchington, S. A. K. Harvey, and R. L. Hendricks. 2005. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. 79: 10339-10347. (Pubitemid 41098574)